ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
-0.02%
US Tech 100
20,355.20
0.45%
S&P 500
6,021.63
0.57%
US Dollar vs CAD
1.40655
0.08%
Bitcoin
92,670.23
0.76%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) News

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateTimeSourceHeadlineSymbolCompany
11/25/20246:00AMGlobeNewswire Inc.Boundless Bio to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
11/07/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
11/07/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
11/07/20243:01PMGlobeNewswire Inc.Boundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:BOLDBoundless Bio Inc
11/05/20246:00AMGlobeNewswire Inc.Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
10/15/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
10/14/20247:00AMGlobeNewswire Inc.Boundless Bio Announces Departure of Chief Financial OfficerNASDAQ:BOLDBoundless Bio Inc
09/11/20246:00AMGlobeNewswire Inc.Boundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
08/20/20246:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BOLDBoundless Bio Inc
08/20/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
08/12/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
08/12/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
08/12/20243:01PMGlobeNewswire Inc.Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsNASDAQ:BOLDBoundless Bio Inc
06/05/20246:00AMBusiness WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
05/13/20246:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
05/13/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
05/13/20246:00AMBusiness WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
05/06/20247:00AMBusiness WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
04/11/20247:00AMBusiness WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
04/08/20247:00AMBusiness WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
02/14/20204:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20203:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20203:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/11/20203:41PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
02/05/202010:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
01/27/20208:38AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
01/21/20205:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
01/21/20205:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
12/03/20196:13PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
12/02/20195:01PMBusiness WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD

Your Recent History

NASDAQ
SAVA
Cassava Sciences
USOTC
CBDW
1606 (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
MONI
Moon Equity (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
NASDAQ
AVXL
Anavex Life Sciences
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
ERHE
ERHC Energy (CE)
NYSE
AMC
AMC Entertainment
USOTC
HIRU
Hiru (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
GVSI
Good Vibrations Shoes (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68